Torii Pharmaceutical Co., Ltd.
TRXPF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $60 | $55 | $49 | $47 |
| % Growth | 10.6% | 11.7% | 4.1% | – |
| Cost of Goods Sold | $34 | $32 | $26 | $23 |
| Gross Profit | $27 | $23 | $23 | $24 |
| % Margin | 44.2% | 41.7% | 47.8% | 51.8% |
| R&D Expenses | $3 | $3 | $2 | $1 |
| G&A Expenses | $2 | $2 | $2 | $0 |
| SG&A Expenses | $4 | $4 | $3 | $4 |
| Sales & Mktg Exp. | $2 | $2 | $2 | $4 |
| Other Operating Expenses | $13 | $11 | $13 | $15 |
| Operating Expenses | $20 | $18 | $18 | $20 |
| Operating Income | $7 | $5 | $6 | $5 |
| % Margin | 11.3% | 9.2% | 11.3% | 9.9% |
| Other Income/Exp. Net | -$0 | $1 | $0 | $0 |
| Pre-Tax Income | $7 | $6 | $6 | $5 |
| Tax Expense | $2 | $1 | $2 | $1 |
| Net Income | $5 | $4 | $4 | $3 |
| % Margin | 8.3% | 7.5% | 8.1% | 7.2% |
| EPS | 179.46 | 146.57 | 140.38 | 120.11 |
| % Growth | 22.4% | 4.4% | 16.9% | – |
| EPS Diluted | 179.46 | 146.57 | 140.38 | 120.11 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $7 | $6 | $6 | $5 |
| % Margin | 11.8% | 11.1% | 12.2% | 10.7% |